JohnPatrickChuteMD

Hematologic Oncology

Professor, Medicine, Duke Univ Sch of Med

Dr. Chute is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

National Capital ConsortiumFellowship, Hematology and Medical Oncology, 1993 - 1996
Georgetown University School of MedicineClass of 1990

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Elected Member The American Society for Clinical Investigation, 2010

PubMed

44 citations
Myeloablative Intravenous Busulfan/Fludarabine Conditioning Does Not Facilitate Reliable Engraftment of Dual Umbilical Cord Blood Grafts in Adult Recipients
Mitchell E. Horwitz, Ashley Morris, Cristina Gasparetto, Keith M. Sullivan, Gwynn D. Long
Biology of Blood and Marrow Transplantation. 2008-05-01
40 citations
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment.
Junya Kanda, Leylagül Kaynar, Yoshinobu Kanda, Vinod K. Prasad, Suhag Parikh
Bone Marrow Transplantation. 2013-01-21
5 citations
Syndecan-2 expression enriches for hematopoietic stem cells and regulates stem cell repopulating capacity.
Christina M. Termini, Amara Pang, Michelle Li, Tiancheng Fang, Vivian Y. Chang
Blood. 2021-09-10

A Leading-Edge Lymphoma ProgramDecember 21st, 2022
Stem Cell Discovery Could Help Shorten Cancer Treatment RecoveryFebruary 2nd, 2022
Discoveries Could Lead to Better Stem Cell TreatmentsJanuary 31st, 2022
Join now to see all